Try a new search

Format these results:

Searched for:

in-biosketch:true

person:duvvuu01

Total Results:

238


Phase I study of cetuximab, intensity-modulated radiotherapy (C-IMRT), and intratumoral EGFR antisense (AS) DNA in patients with locally advanced head and neck cancer (HNC) [Meeting Abstract]

Bauman, Julie E.; Duvvuri, Umamaheswar; Gooding, William E.; Clump, David Andrew; Karlovits, Brian J.; Wehbe, Ahmad Mouhamad; Miller, Frank R.; Johnson, Jonas Talmadge; Ferris, Robert L.; Kim, Seungwon; Heron, Dwight Earl; Ohr, James; Grandis, Jennifer R.; Argiris, Athanassios
ISI:000358036901391
ISSN: 0732-183x
CID: 5482562

Outcomes for Carotid Blowout Interventions in Patients With Head and Neck Cancer [Meeting Abstract]

Liang, Nathan L.; Guedes, Brian D.; Duvvuri, Umamaheswar; Singh, Michael J.; Chaer, Rabih A.; Makaroun, Michel S.; Sachdev, Ulka
ISI:000360357500066
ISSN: 0741-5214
CID: 5482592

HER3 inhibition potentiates anti-tumor effects of PI3K inhibitors in pre-clinical models of HNSCC [Meeting Abstract]

Davis, Kara S.; Khan, Nayel; Kemp, Carolyn; Kulkarni, Sucheta; Alvarado, Diego; LaVallee, Theresa; Grandis, Jennifer R.; Duvvuri, Umamaheswar
ISI:000371578503164
ISSN: 0008-5472
CID: 5482602

Influence of chloride flux on cell motility in head and neck squamous cell carcinoma [Meeting Abstract]

Khan, Nayel; Steehler, Kevin; Kemp, Carolyn; Kulkarni, Sucheta; Davis, Kara; Duvvuri, Umamaheswar
ISI:000371597105284
ISSN: 0008-5472
CID: 5482612

Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay

Nikiforov, Yuri E; Carty, Sally E; Chiosea, Simon I; Coyne, Christopher; Duvvuri, Umamaheswar; Ferris, Robert L; Gooding, William E; Hodak, Steven P; LeBeau, Shane O; Ohori, N Paul; Seethala, Raja R; Tublin, Mitchell E; Yip, Linwah; Nikiforova, Marina N
BACKGROUND: Fine-needle aspiration (FNA) cytology is a common approach to evaluating thyroid nodules, although 20% to 30% of FNAs have indeterminate cytology, which hampers the appropriate management of these patients. Follicular (or oncocytic) neoplasm/suspicious for a follicular (or oncocytic) neoplasm (FN/SFN) is a common indeterminate diagnosis with a cancer risk of approximately 15% to 30%. In this study, the authors tested whether the most complete next-generation sequencing (NGS) panel of genetic markers could significantly improve cancer diagnosis in these nodules. METHODS: The evaluation of 143 consecutive FNA samples with a cytologic diagnosis of FN/SFN from patients with known surgical outcomes included 91 retrospective samples and 52 prospective samples. Analyses were performed on a proprietary sequencer using the targeted ThyroSeq v2 NGS panel, which simultaneously tests for point mutations in 13 genes and for 42 types of gene fusions that occur in thyroid cancer. The expression of 8 genes was used to assess the cellular composition of FNA samples. RESULTS: In the entire cohort, histologic analysis revealed 104 benign nodules and 39 malignant nodules. The most common point mutations involved the neuroblastoma RAS viral oncogene homolog (NRAS), followed by the Kirsten rat sarcoma viral oncogene homolog (KRAS), the telomerase reverse transcriptase (TERT) gene, and the thyroid-stimulating hormone receptor (TSHR) gene. The identified fusions involved the thyroid adenoma associated (THADA) gene; the peroxisome proliferator-activated receptor gamma (PPARG) gene; and the neurotrophic tyrosine kinase, receptor, type 3 (NTRK3) gene. Performance characteristics were similar in the retrospective and prospective groups. Among all FN/SFN nodules, preoperative ThyroSeq v2 performed with 90% sensitivity (95% confidence interval [CI], 80%-99%), 93% specificity (95% CI, 88%-98%), a positive predictive value of 83% (95% CI, 72%-95%), a negative predictive value of 96% (95% CI, 92%-100%), and 92% accuracy (95% CI, 88%-97%). CONCLUSIONS: The current results indicate that comprehensive genotyping of thyroid nodules using a broad NGS panel provides a highly accurate diagnosis for nodules with FN/SFN cytology and should facilitate the optimal management of these patients. Cancer 2014. (c) 2014 American Cancer Society.
PMID: 25209362
ISSN: 0008-543x
CID: 1258262

Erratum: "Colloid-Rich" follicular neoplasm/suspicious for follicular neoplasm thyroid fine-needle aspiration specimens: Cytologic, histologic, and molecular basis for considering an alternate view (Cancer Cytopathology (2013) 121 (718-728))

Ohori, N. P.; Wolfe, J.; Hodak, S. P.; LeBeau, S. O.; Yip, L.; Carty, S. E.; Duvvuri, U.; Schoedel, K. E.; Nikiforova, M. N.; Nikiforov, Y. E.
SCOPUS:84930010320
ISSN: 1934-662x
CID: 5487602

Transoral robotic surgery for pharyngeal stenosis [Case Report]

Byrd, James K; Leonardis, Rachel L; Bonawitz, Steven C; Losee, Joseph E; Duvvuri, Umamaheswar
BACKGROUND:Pharyngeal stenosis is a complication of head and neck cancer and sleep apnea treatment that results in functional impairment. Due to the location of the stenosis and tendency to recur, surgical management is challenging. Robotic surgery may allow these areas to be treated with surgical technique that would be difficult using traditional approaches. METHODS:A retrospective chart review was performed to identify patients who underwent transoral robotic surgery (TORS) for pharyngeal stenosis at a tertiary hospital system. RESULTS:Five patients were identified, ages 8-75 years. Length of follow-up ranged from 1-12 months. There was one failure, a 74 year old male with a history of chemoradiation to the area who has required additional procedures. CONCLUSION/CONCLUSIONS:TORS may offer improved surgical access to the pharynx in patients who require complex reconstruction that would otherwise be very difficult. Appropriate patient selection is necessary and long-term follow-up is warranted for the selected cases.
PMID: 24737499
ISSN: 1478-596x
CID: 5481292

Robot-assisted level II-IV neck dissection through a modified facelift incision: initial North American experience

Greer Albergotti, W; Kenneth Byrd, J; De Almeida, John R; Kim, Seungwon; Duvvuri, Umamaheswar
BACKGROUND:Cosmesis is of increasing importance to the otolaryngology patient population. This is the first report of clinical outcomes of robot-assisted neck dissection by North American groups. METHODS:This is a retrospective case-control study. Cases included three patients who underwent isolated, ipsilateral robot-assisted neck dissection. Operative time, estimated blood loss, lymph node retrieval, total drainage, hospital stay and complications from this group were compared against the outcomes of six consecutive patients who underwent conventional neck dissection. RESULTS:Operative times were longer in robot-assisted neck dissection (mean 234 min) compared with the conventional neck dissection (mean 110 min). There were no significant differences between the two groups in other outcomes. CONCLUSIONS:Robot-assisted selective neck dissection of levels II-IV is feasible through a modified facelift incision. Our initial data suggest that this procedure is surgically sound. It should be applied by experienced surgeons who wish to avoid a cervical incision.
PMID: 24760419
ISSN: 1478-596x
CID: 5481302

Cost-effectiveness of transoral robotic surgery in the unknown primary: corrigendum and response to comments [Comment]

Byrd, J Kenneth; Smith, Kenneth J; de Almeida, John R; Ferris, Robert L; Duvvuri, Umamaheswar
PMID: 25452332
ISSN: 1097-6817
CID: 5481342

Principles of radiation oncology

Chapter by: Duvvuri, Umamaheswar; Kubicek, Gregory J.
in: Bailey's Head and Neck Surgery: Otolaryngology by
[S.l.] : Wolters Kluwer Health, 2014
pp. 1682-1691
ISBN: 9781609136024
CID: 5487822